Retatrutide

Retatrutide

Retatrutide is a unimolecular triple agonist peptide at the GLP-1, GIP, and glucagon receptors, studied as a research material. This listing is for laboratory research use only. It is not a drug, food, cosmetic, or dietary supplement, and it is not approved for human or veterinary use.

Research Context

Retatrutide appears in the scientific literature as a triple incretin/glucagon-receptor agonist examined in metabolic experimental systems. Informal catalog labels such as “GLP-3” are not a separate receptor class; this listing uses the compound name. This page does not describe administration, dosing, or personal use.

Research Overview

Published work has examined retatrutide in controlled experimental systems of simultaneous GLP-1R, GIPR, and GCGR signaling. Findings from those models are not established as safe or effective for people or animals, and nothing here is medical advice.

Key Research Focus Areas

• Triple GLP-1 / GIP / glucagon receptor-agonist identity
• Incretin and glucagon-receptor signaling assays
• Energy-balance and metabolic laboratory models
• Distinction from dual agonists and GLP-1-only analogs

Important Disclaimer

For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not medical advice. Handle only in a qualified research setting and in compliance with applicable law.